Angiodynamics ANGO
NASDAQ ANGO
$15.16 +0.04 (+0.26%)
As of: Oct 2, 2026 · 11:17 AM EDT

Angiodynamics (ANGO) Depreciation and Depletion (2014 - 2015)

Updated

Angiodynamics (ANGO) posted Depreciation and Depletion of $10.5 million for FY2026 (year ended May 31, 2026), down 22.2% from $13.5 million in FY2025.

Analysis

Angiodynamics (ANGO) Depreciation and Depletion (2014 - 2015) Analysis & Trends

Since FY2011, Angiodynamics has reported Depreciation and Depletion for 16 fiscal years.

  • Annual Depreciation and Depletion shows a five-year compound annual growth rate of 13.0% (FY2021 to FY2026).
  • The FY2026 figure stands as the lowest annual Depreciation and Depletion since FY2022.
  • Business Quant data shows ANGO's Depreciation and Depletion at $13.5 million in FY2025 (-8.2%), $14.7 million in FY2024 (+23.5%), $11.9 million in FY2023 (+56.6%) and $7.6 million in FY2022 (+33.3%).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Dep. & Depletion (Qtr)
1 Thermo Fisher Scientific 249.71 Bn 228.86 Bn 4.88 Bn 331.00 Mn
2 Abbott Laboratories 171.00 Bn 142.08 Bn 7.27 Bn 402.00 Mn
3 Danaher 155.79 Bn 139.61 Bn 3.61 Bn 196.00 Mn
4 Intuitive Surgical 143.91 Bn 123.46 Bn 1.96 Bn -
5 Medtronic 110.42 Bn 76.29 Bn 6.34 Bn 317.00 Mn
6 Stryker 105.71 Bn 91.82 Bn 4.50 Bn 121.00 Mn
7 Boston Scientific 63.26 Bn 58.27 Bn 3.85 Bn 122.00 Mn
8 Edwards Lifesciences 49.80 Bn 33.91 Bn 1.35 Bn -
9 Becton Dickinson 48.78 Bn 45.93 Bn 2.32 Bn -
10 Angiodynamics 641.35 Mn 469.28 Mn 46.77 Mn -
Historic Data

Historic Data

Download Data
DateValue
May 31, 2015 9.40 Mn
Aug 31, 2014 400,000.00
API Access

Angiodynamics Depreciation and Depletion API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=depreciation-and-depletion&ticker=ANGO&period=max&api_key=YOUR_API_KEY